Aug 09, 2018
InDex Pharmaceuticals Updates Timeline for Top Line Results from the CONDUCT Study to First Half of 2019
Aug 06, 2018
Final Results from the Protagonist PROPEL Study Support Further Clinical Development of PTG-100 for the Treatment of Ulcerative Colitis
Jun 05, 2018
DDW 2018: Patients with Moderate-to-Severe Ulcerative Colitis Achieved Clinical and Endoscopic Remission with Mirikizumab in Phase 2 Trial
Jun 01, 2018
Lilly to Showcase New Data at Digestive Disease Week 2018 for Mirikizumab in Moderate-to-Severe Ulcerative Colitis
May 30, 2018
Oshi Health Launches First All-in-One Mobile App to Empower Patients with Inflammatory Bowel Disease (IBD), including Crohn's Disease and Ulcerative Colitis
Apr 12, 2018
InDex Pharmaceuticals Announces the Agenda for its Capital Markets Day in Stockholm on April 25, 2018
Mar 28, 2018
InDex Pharmaceuticals gets New Patent in Japan
Mar 27, 2018
Daiichi Sankyo, Inc. and the Crohn's & Colitis Foundation Launch Get Iron Informed
Mar 19, 2018
Arena Pharmaceuticals Reports Positive Phase 2 Results from the OASIS Trial for Etrasimod in Patients with Ulcerative Colitis
Feb 13, 2018
InDex Pharmaceuticals Presents Mechanism of Action Data for Cobitolimod at the ECCO Congress
Feb 12, 2018
Ferring's CLENPIQ(TM) (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep Now Available
Jan 23, 2018
Takeda Utilizes Social Media Analysis and Survey in a Study to Better Understand Patient Preferences When Seeking Treatment for Inflammatory Bowel Disease
Dec 01, 2017
InDex Pharmaceuticals Reports New Mechanism of Action Data for Cobitolimod
Nov 29, 2017
FDA Approves Ferring's CLENPIQ(TM) (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep
Nov 17, 2017
InDex Pharmaceuticals Holding AB (publ) Interim Report January - September 2017
Nov 01, 2017
Crohn's and Colitis Canada wants businesses large and small to open their washrooms to those in need
Oct 30, 2017
Crohn's & Colitis Foundation Receives $5 Million to Fund Innovative Translational and Clinical IBD Research
Oct 12, 2017
InDex Pharmaceuticals Gets New Patent in the U.S.
Sep 19, 2017
Crohn's & Colitis Foundation partners with Oxford University Press to publish Inflammatory Bowel Diseases® journal
Sep 13, 2017
InDex Pharmaceuticals Gets New Patent Granted in Japan